NUNZ.US Nunzia Pharmaceutical Corporation

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Nov 17, 2025
0.0001 0.0001
Market cap
USD 43.5K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.

Is NUNZ.US undervalued?

Graham number

The Graham number of Nunzia Pharmaceutical Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nunzia Pharmaceutical Corporation fundamental analysis

No fundamental analysis for Nunzia Pharmaceutical Corporation yet.

Nunzia Pharmaceutical Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nunzia Pharmaceutical Corporation

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nun…

Full company profile